Biolase

Needham Positive on Biolase (NASDAQ:BLTI) over Long Term

Citing the recent restructuring of the HSIC deal, and several other postive developments, Needham says they’re postive on Biolase Technology (NASDAQ:BLTI) over the long term. Needham said, “In addition to the restructuring of the HSIC deal, the company has had a number of recent positive developments that give us reason for optimism about its long term prospects: BLTI has already received a

Continue Reading »